SNOASonoma Pharmaceuticals, Inc.

Nasdaq sonomapharma.com


$ 0.20 $ 0.00 (-2.44 %)    

Friday, 31-May-2024 15:19:02 EDT
QQQ $ 454.82 $ -1.28 (-0.28 %)
DIA $ 398.57 $ 3.61 (0.95 %)
SPY $ 530.36 $ 0.68 (0.13 %)
TLT $ 91.26 $ -0.06 (-0.07 %)
GLD $ 225.37 $ -2.06 (-0.95 %)
$ 0.205
$ 0.19
$ 0.00 x 0
$ 0.21 x 600
$ 0.19 - $ 0.20
$ 0.12 - $ 1.52
6,784,003
na
3.2M
$ 1.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-08-2024 12-31-2023 10-Q
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 06-21-2023 03-31-2023 10-K
5 02-14-2023 12-31-2022 10-Q
6 11-14-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 07-13-2022 03-31-2022 10-K
9 02-11-2022 12-31-2021 10-Q
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 07-14-2021 03-31-2021 10-K
13 02-16-2021 12-31-2020 10-Q
14 11-20-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 07-10-2020 03-31-2020 10-K
17 02-14-2020 12-31-2019 10-Q
18 11-14-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 07-01-2019 03-31-2019 10-K
21 02-14-2019 12-31-2018 10-Q
22 11-08-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 06-26-2018 03-31-2018 10-K
25 02-14-2018 12-31-2017 10-Q
26 11-14-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 06-28-2017 03-31-2017 10-K
29 02-17-2017 12-31-2016 10-Q
30 11-15-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 06-21-2016 03-31-2016 10-K
33 02-16-2016 12-31-2015 10-Q
34 11-10-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 06-16-2015 03-31-2015 10-K
37 02-12-2015 12-31-2014 10-Q
38 11-13-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 06-30-2014 03-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonoma-pharmaceuticals-announced-the-expansion-of-its-microcyn-negative-pressure-wound-therapy-npwt-solution-products-in-the-us

Microcyn Negative-Pressure Wound Therapy Solution, an innovation in advanced wound care, is now available in convenient sizes o...

 sonoma-pharmaceuticals-highlights-safety-advantages-of-microcyn-products

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...

 sonoma-pharmaceuticals-q3-eps-008-up-from-062-yoy-sales-314m-up-from-294m-yoy

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.08) per share. This is a 87.1 percent increase over losse...

 why-netflix-shares-are-trading-higher-by-10-here-are-20-stocks-moving-premarket

Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-e...

Core News & Articles

The new products will combine Sonoma's existing eye product Ocudox®, which has already received a Class IIB CE mark for sal...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION